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BOOK REVIEWS
Teratocarcinoma and Embryonic Cell Interactions.
(Eds. T. MURAMATSU, G. GACHELIN, A. A.
MOSCONA and Y. IKAWA) UK, Academic Press,
Inc, 344 pp, 1982, £23.80.
We are living in the golden age of molecular and
cellular biology. New discoveries assail us from the
pages of "learned" journals and are often published
first in the daily newspapers. At such a time two
years is a long period to wait for a meeting report
which summarises an area of active research. The
editors have attempted to ameliorate this problem
by writing a summary of the advances made in
teratocarcinoma research between 1980 and the
publication date. Unfortunately, this serves to
emphasise the problem and increases the
introduction section of the book to the record
proportions of two Forewords, a Preface and two
Editorial Notes.
Teratocarcinomas are a focal point where tumour
biology and developmental biology meet. This
confluence has contributed much to concepts in
tumour biology and is currently apparent in the
study of high molecular weight carbohydrate
structures found on murine embryos and
teratocarcinoma stem cells and on many human
tumour cells. The clustering of related papers on
the same topic is one of the advantages that a
meeting report has compared with conventional
publication and the editors are to be congratulated
on their prescience in selecting carbohydrate
biochemistry as a major theme of their meeting.
Another advantage the meeting report has over
journal publication is the possibility of including
discussion of presented papers. These sections in
the book make exciting reading being, apparently,
faithful transcripts even down to the theatrical
gestures of the speakers. In conclusion, this book,
by its very nature, is dated in content and nearly all
the work is published elsewhere; this disadvantage
is partially offset by being a convenient, single
volume, summary of the teratocarcinoma story as it
was in 1980.
P.N. Goodfellow
Imperial Cancer Research Fund Laboratories,
Lincoln's Inn Fields,
London WC2
Mutagenicity-New Horizons in Genetic Toxicology.
(Ed. J. A. HEDDLE) UK, Academic Press Inc., 471
pp, 1982, £36.40.
This is a rather expensive collection of 16 chapters
intended to illustrate the very wide range of
problems which can be tackled by applying short-
term mutagenicity tests. The book starts with
microbial tests, follows with chapters on cultured
mammalian cells, tests based on sampling cells from
human populations, and ends with two chapters on
monitoring environmental pollution using higher
plants and fish as indicators of genetic damage.
The selection of subject matter is rather quirky.
There are two chapters on the use and relevance of
short-term tests for detecting mutagens in food
(Sugimura and Nago; Stich, et al.) but nothing on
the use of mutagenicity tests for looking for
endogenous mutagens in body fluids and excreta-
surely a "new horizon" and fascinating if only for
the enormous problems attendant upon such
studies. A chapter on the use of short-term tests for
monitoring water supplies is also lacking.
The book starts with John Ashby's stimulating
views on the value of short-term tests for predicting
long-term effects such as carcinogenicity. In the
preface, the Editor (John Heddle) alludes to the
"explosive growth" in this area, and in one respect,
Ashby has been caught in the blast. He dwells upon
the challenge to genotoxicology posed by the
inability of ethylene oxide (a potent, directly-acting
alkylating mutagen) to induce tumours at the site
of application-the respiratory tract of animals
dosed by inhalation. This is an unusual finding for
a directly-acting alkylating agent. He makes much
of tumours (testicular mesotheliomas) which arose
remote from the application site, and suggests that
the bacterial mutagenicity of ethylene oxide resides
in the activity of the parent molecule, and that the
"indirect" carcinogenic effect in mammals may be
due to a metabolite: this may be so. However, like
the unfortunate Richard III, Ashby runs before his
horse to market, since ethylene oxide does induce
tumours at the site of application. Dunkelberg (Br.
J. Cancer, 46: 924, 1982) force-fed rats with it and
produced squamous-cell carcinomas of the fore-
stomach. Even after 3 years, this treatment did not
induce tumours remote from the application site.
This illustrates the dangers of over-interpreting
short-term data (which are easy to collect and
therefore plentiful) and using them to erect
elaborate hypotheses to explain scarce and
sometimes dubious data from long-term
experiments. However, Ashby has done us a service
by airing these problems.
There follows a useful chapter by Bartsch,
Tomatis and Malaveille, who have exploited the
valuable resources of the IARC to produce some
excellent summaries relating Ames-test data on
selected carcinogens to the Covalent Binding Index
of Lutz. They discuss in some depth the possibility